Oncotarget: Hispanic Chronic myelomonocytic leukemia patients
This Oncotarget study had significantly lower mutation rates in ASXL1 and SETBP1, and a higher rate of muTET2/wtASXL1Credit: Correspondence to ...
This Oncotarget study had significantly lower mutation rates in ASXL1 and SETBP1, and a higher rate of muTET2/wtASXL1Credit: Correspondence to ...
Dr. Glenn J. Hanna from CCR/NCI in Bethesda, MD as well as The Dana-Farber Cancer Institute in Boston Massachusetts said, ...
The Oncotarget data shed new light on the biochemical mechanisms behind ibuprofen's action on alternative spliced RAC1B and may support ...
Credit: LSU The Louisiana State University School of Veterinary Medicine, or LSU SVM, has received an $11 million grant to ...
The present Oncotarget work shed light on a brief mechanistic framework of PTs aggressive nature and present potential biomarkers to ...
Credit: Marianna Kruithof-de Julio and Marta De Menna In the EU alone, 78,800 men died of prostate cancer last year. ...
Credit: FEFU press office Scientists from Far Eastern Federal University (FEFU) together with Russian and German colleagues, continue studying antitumor ...
Credit: DOI: 10.1038/s41586-021-03211-0 Many genetic variants have been found to have a linkage with genetic diseases, but the understanding of ...
Macrophages that boost tumor growthCredit: UNIVERSITY OF BARCELONA Tumor cells are able to avoid the attack of the immune system ...
Research offers new lead for cancer drug discoveryCredit: Rensselaer Polytechnic Institute TROY, N.Y. -- An antioxidant found in green tea ...
'The established mouse cachexia model can therefore be considered useful for analyzing cancer-derived myocardial damage'Credit: Correspondence to - Yi Luo ...
'The results of the use of melatonin drugs in palliative treatment of patients with end-stage prostate cancer are shown'Credit: Correspondence ...
Credit: Image created by K Lueckerath, UCLA. Reston, VA--A combination of radionuclide therapy and immunotherapy has proven successful in slowing ...
Altered epigenetic marks on ribosomal RNAs appear to create a pool of specialized ribosomes that can differentially regulate translation of ...
Dr. Mikhail V. Blagosklonny from The Roswell Park Cancer Institute said, 'Although we do not know everything about aging, we ...
The objective of this Oncotarget study was to elucidate the molecular mechanism of actions of 2MeOE2, a known microtubule disrupting ...
"Simvastatin efficiently controlled OCCC proliferation and migration, thus showing potential as a candidate drug for the treatment of OCCC."Credit: Correspondence ...
"The Oncotarget author's findings show that MRI is reliable for T staging of cervical NEC"Credit: Correspondence to - Kazuhiro Kitajima ...
Method may also work for breast, prostate, ovarian cancerCredit: Jeff Gates Researchers with the Kansas City Veterans Affairs Medical Center ...
The Oncotarget authors show that the drug-resistant, metastasis-causing cells are capable of producing drug-resistant, exponentially growing tumors, responsible for tumor ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.